Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-258596
Filing Date
2025-10-30
Accepted
2025-10-30 16:20:49
Documents
69
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstv-20250930.htm   iXBRL 10-Q 2741995
2 EX-10.2 pstv-ex10_2.htm EX-10.2 187126
3 EX-10.3 pstv-ex10_3.htm EX-10.3 63966
4 EX-31.1 pstv-ex31_1.htm EX-31.1 15730
5 EX-31.2 pstv-ex31_2.htm EX-31.2 12615
6 EX-32.1 pstv-ex32_1.htm EX-32.1 17939
  Complete submission text file 0001193125-25-258596.txt   10500313

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pstv-20250930.xsd EX-101.SCH 1360350
72 EXTRACTED XBRL INSTANCE DOCUMENT pstv-20250930_htm.xml XML 1664001
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34375 | Film No.: 251435935
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)